Participation of Fos and Jun in multistage carcinogenesis

Adam Bleier Glick, Stuart H. Yuspa

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

The discovery that transforming genes of oncogenic retroviruses are transduced variants of eucaryotic genes launched the current era of molecular carcinogenesis. The interpretation of that discovery and the molecular insights that followed, however, depended on the foundation established by four prior decades of carcinogenesis research. Studies in animals had established that certain chemicals could cause malignant tumors, that cancer induction is a multistage process, and that carcinogenesis is organ specific in humans and other mammals (Yuspa and Poirier, 1988). Subsequent studies in cell culture proved that neoplastic transformation by chemicals is inductive rather than selective, and that somatic mutations are an important component of cancer pathogenesis. Cellular enzymes were identified that activated or detoxified chemical carcinogens, and DNA was recognized as the critical target for activated carcinogens (Miller, 1978). The development of methods to evaluate carcinogenesis in cultured human cells provided the foundation for studies of comparative carcinogenesis at the molecular level (Yuspa and Poirier, 1988; Harris, 1991). While recent genetic analyses have defined intimate details of the cellular pathways that are altered in response to carcinogenic stimuli and revealed the structural basis for many of these alterations, they must be evaluated in the context of cancer's multiple stages: initiation, promotion, and malignant conversion (Yuspa and Poirier, 1988; Harris, 1991).

Original languageEnglish (US)
Title of host publicationThe FOS and JUN Families of Transcription Factors
PublisherCRC Press
Pages275-293
Number of pages19
ISBN (Electronic)9781351357128
ISBN (Print)9781138506503
DOIs
StatePublished - Jan 1 2017

Fingerprint

Carcinogenesis
Carcinogens
Genes
Mammals
Neoplasms
Cell culture
Tumors
Animals
Cells
Retroviridae
Oncogenes
DNA
Enzymes
Cultured Cells
Cell Culture Techniques
Mutation
Research

All Science Journal Classification (ASJC) codes

  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Glick, A. B., & Yuspa, S. H. (2017). Participation of Fos and Jun in multistage carcinogenesis. In The FOS and JUN Families of Transcription Factors (pp. 275-293). CRC Press. https://doi.org/10.1201/9780203710036
Glick, Adam Bleier ; Yuspa, Stuart H. / Participation of Fos and Jun in multistage carcinogenesis. The FOS and JUN Families of Transcription Factors. CRC Press, 2017. pp. 275-293
@inbook{7f17074e58d747ab9c087492e235c488,
title = "Participation of Fos and Jun in multistage carcinogenesis",
abstract = "The discovery that transforming genes of oncogenic retroviruses are transduced variants of eucaryotic genes launched the current era of molecular carcinogenesis. The interpretation of that discovery and the molecular insights that followed, however, depended on the foundation established by four prior decades of carcinogenesis research. Studies in animals had established that certain chemicals could cause malignant tumors, that cancer induction is a multistage process, and that carcinogenesis is organ specific in humans and other mammals (Yuspa and Poirier, 1988). Subsequent studies in cell culture proved that neoplastic transformation by chemicals is inductive rather than selective, and that somatic mutations are an important component of cancer pathogenesis. Cellular enzymes were identified that activated or detoxified chemical carcinogens, and DNA was recognized as the critical target for activated carcinogens (Miller, 1978). The development of methods to evaluate carcinogenesis in cultured human cells provided the foundation for studies of comparative carcinogenesis at the molecular level (Yuspa and Poirier, 1988; Harris, 1991). While recent genetic analyses have defined intimate details of the cellular pathways that are altered in response to carcinogenic stimuli and revealed the structural basis for many of these alterations, they must be evaluated in the context of cancer's multiple stages: initiation, promotion, and malignant conversion (Yuspa and Poirier, 1988; Harris, 1991).",
author = "Glick, {Adam Bleier} and Yuspa, {Stuart H.}",
year = "2017",
month = "1",
day = "1",
doi = "10.1201/9780203710036",
language = "English (US)",
isbn = "9781138506503",
pages = "275--293",
booktitle = "The FOS and JUN Families of Transcription Factors",
publisher = "CRC Press",

}

Glick, AB & Yuspa, SH 2017, Participation of Fos and Jun in multistage carcinogenesis. in The FOS and JUN Families of Transcription Factors. CRC Press, pp. 275-293. https://doi.org/10.1201/9780203710036

Participation of Fos and Jun in multistage carcinogenesis. / Glick, Adam Bleier; Yuspa, Stuart H.

The FOS and JUN Families of Transcription Factors. CRC Press, 2017. p. 275-293.

Research output: Chapter in Book/Report/Conference proceedingChapter

TY - CHAP

T1 - Participation of Fos and Jun in multistage carcinogenesis

AU - Glick, Adam Bleier

AU - Yuspa, Stuart H.

PY - 2017/1/1

Y1 - 2017/1/1

N2 - The discovery that transforming genes of oncogenic retroviruses are transduced variants of eucaryotic genes launched the current era of molecular carcinogenesis. The interpretation of that discovery and the molecular insights that followed, however, depended on the foundation established by four prior decades of carcinogenesis research. Studies in animals had established that certain chemicals could cause malignant tumors, that cancer induction is a multistage process, and that carcinogenesis is organ specific in humans and other mammals (Yuspa and Poirier, 1988). Subsequent studies in cell culture proved that neoplastic transformation by chemicals is inductive rather than selective, and that somatic mutations are an important component of cancer pathogenesis. Cellular enzymes were identified that activated or detoxified chemical carcinogens, and DNA was recognized as the critical target for activated carcinogens (Miller, 1978). The development of methods to evaluate carcinogenesis in cultured human cells provided the foundation for studies of comparative carcinogenesis at the molecular level (Yuspa and Poirier, 1988; Harris, 1991). While recent genetic analyses have defined intimate details of the cellular pathways that are altered in response to carcinogenic stimuli and revealed the structural basis for many of these alterations, they must be evaluated in the context of cancer's multiple stages: initiation, promotion, and malignant conversion (Yuspa and Poirier, 1988; Harris, 1991).

AB - The discovery that transforming genes of oncogenic retroviruses are transduced variants of eucaryotic genes launched the current era of molecular carcinogenesis. The interpretation of that discovery and the molecular insights that followed, however, depended on the foundation established by four prior decades of carcinogenesis research. Studies in animals had established that certain chemicals could cause malignant tumors, that cancer induction is a multistage process, and that carcinogenesis is organ specific in humans and other mammals (Yuspa and Poirier, 1988). Subsequent studies in cell culture proved that neoplastic transformation by chemicals is inductive rather than selective, and that somatic mutations are an important component of cancer pathogenesis. Cellular enzymes were identified that activated or detoxified chemical carcinogens, and DNA was recognized as the critical target for activated carcinogens (Miller, 1978). The development of methods to evaluate carcinogenesis in cultured human cells provided the foundation for studies of comparative carcinogenesis at the molecular level (Yuspa and Poirier, 1988; Harris, 1991). While recent genetic analyses have defined intimate details of the cellular pathways that are altered in response to carcinogenic stimuli and revealed the structural basis for many of these alterations, they must be evaluated in the context of cancer's multiple stages: initiation, promotion, and malignant conversion (Yuspa and Poirier, 1988; Harris, 1991).

UR - http://www.scopus.com/inward/record.url?scp=85053352824&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85053352824&partnerID=8YFLogxK

U2 - 10.1201/9780203710036

DO - 10.1201/9780203710036

M3 - Chapter

AN - SCOPUS:85053352824

SN - 9781138506503

SP - 275

EP - 293

BT - The FOS and JUN Families of Transcription Factors

PB - CRC Press

ER -

Glick AB, Yuspa SH. Participation of Fos and Jun in multistage carcinogenesis. In The FOS and JUN Families of Transcription Factors. CRC Press. 2017. p. 275-293 https://doi.org/10.1201/9780203710036